KAPA - Kairos Pharma Sof marja

Kairos Pharma Inc (KAPA) tovar belgisi

Kairos Pharma Ltd (KAPA) innovatsiyalariga shifokorlarning kuchli ishonchi, tushum marjasi ko'rsatkichi bilan tasdiqlanganidek, investorlar qiziqishini saqlab qolmoqda. 0.00 belgisi joriy rentabellik darajasini ko'rsatadi. Biznes barqarorligi AQSh markazlarida noyob molekulalarni ishlab chiqishga tayanadi, prostata va o'pka saratoni davolash uchun klinik sinovlar portfelining diversifikatsiyasi esa potentsial muvaffaqiyatsizlik xatarlarini minimallashtiradi.

Kairos Pharma Limited (KAPA) Kompaniya sotuv marjasi: 17.09.2024 - 20.11.2026 davri uchun

kairospharma.com (KAPA) kompaniyasining tahliliy kesimlari

- bozor qiymati va tahlilchilarning maqsadli prognozi:
Kompaniyaning jamlanma tahliliyoti:Kairos Pharma Inc - KAPA
Kairos Pharma Ltd ishlab chiqargan mahsulot

Kairos Pharma Ltd (KAPA) faoliyati sof savdo marjasi spreadi orqali yaqqol aks etgan. Ushbu ko'rsatkich barcha operatsion va soliq xarajatlari chegirib tashlanganidan keyin tushumdan qolgan foyda qismini belgilaydi. Hisob-kitoblar har bir mahsulot birligining monetizatsiya samaradorligini aniq o'lchash imkonini beradi. Bioteknologiya kompaniyalari uchun ushbu metrikadagi tebranishlar ko'pincha xomashyo ta'minoti zanjirlaridagi uzilishlardan dalolat beradi. Spreadning barqaror o'sishi esa kapitalning geosiyosiy risklarga chidamliligini tasdiqlaydi.

Raqobatchilar tahlili

ONC: Sotuvning sof marjinal rentabelligi|Sof marja Halozyme Inc. (HALO)|Sof marja RevMed|Sotuvning sof rentabelligi AAPG (Ascentage Pharma Group)|Sotuvning sof marjinal rentabelligi CGON|UroGen Pharma - Sotuvning sof rentabelligi|Bicara Therapeutics - Sof foyda bo'yicha sotuv rentabelligi|Sotuvning sof marjinal rentabelligi Personalis Inc PSNL|Erasca Oncology - Sotuvning sof marjinal rentabelligi|Sof foyda normasi DCTH (Delcath Corp)|YMAB: Sotuvning sof marjinal rentabelligi|AURA - Kompaniya sotuv marjasi|CADL (Candel Therapeutics Inc.) - Sotuvning sof marjinal rentabelligi|Sotuvning sof rentabelligi ARAY (Accuray)|Sof foyda bo'yicha sotuv rentabelligi SLS (SELLAS Life Sciences Group, Inc.)|ACTU - Sof marja|Sof marja Citius Oncology, Inc. CTOR|HURA - Sof foyda bo'yicha sotuv rentabelligi|protaratx.com - Sotuvning sof marjinal rentabelligi|FATE - Sotuvning sof marjinal rentabelligi|WHWK: Sotuvning sof marjinal rentabelligi|TScan Therapeutics (TCRX) - Sotuvning sof marjinal rentabelligi|Sof marja Champions Oncology|Sof marja XBIT|Sotuvning sof marjinal rentabelligi CVM|Sof foyda bo'yicha sotuv rentabelligi OS Therapies Inc. OSTX|Sof marja Radiopharm Theranostics Limited RADX|artivabio.com (ARTV) - Sof marja|ANL - Sof marja|Sof marja verupharma.com|TPST: Sotuvning sof marjinal rentabelligi|XLO - Kompaniya sotuv marjasi|Sof marja Renovaro|Sotuvning sof marjinal rentabelligi muraloncology.com|Sotuvning sof marjinal rentabelligi OKUR|CytoMed Therapeutics Limited (GDTC) - Sof foyda bo'yicha marjinallik|Sotuvning sof marjinal rentabelligi CRIS (Curis, Inc.)|APLM: Sotuvning sof rentabelligi|Tharimmune Corporation - Sotuvning sof marjinal rentabelligi|ADVB: Sof marja|GNPX: Sotuvning sof marjinal rentabelligi|CLDI (Calidi Biotherapeutics Inc.) - Sof marja|Sof marja Sunshine Biopharma, Inc.|Sotuvning sof marjinal rentabelligi xeneticbio.com|Sof marja Salarius (SLRX)|Sof foyda bo'yicha sotuv rentabelligi Purple Biotech PPBT|Sof marja American Oncology Network, Inc. AONC|BeiGene, Ltd. (BGNE) - Sof marja|Checkpoint Therapeutics Inc. - Sotuvning sof marjinal rentabelligi|Sof foyda normasi ELEV (Elevation Oncology)|ICAD (iCAD Corp) - Sof foyda bo'yicha sotuv rentabelligi|Ikena Oncology, Inc. - Sof foyda normasi|Sof foyda bo'yicha sotuv rentabelligi NTBL|VIRX: Sof foyda normasi|Sof marja MorphoSys Corporation (MOR)|NAYA - Sof marja|Sotuvning sof marjinal rentabelligi AAPGV (Ascentage)